(Report) 45th Breakfast Meeting
date : 9/19/2013
In May 2013, as a result of how the Hollywood actress Angelina Jolie had boldly shared her experience which she explained of how and why she had underwent mastectomy to prevent the risk of developing breast cancer in the future when she found that mutations in the BRCA1 gene were detected in the genetic testing of hereditary breast ovarian cancer via New York Times The Opinion Pages, the news had turned into a hot topic in Japan.
At almost the same time, “New prenatal diagnosis” was available for the pregnant women to determine the presence of chromosomal abnormalities in fetal blood test in April this year. As the genetic analysis technology advances, examining and predicting future disease of the baby through fetal genetic testing is made possible. However, this has also accompanied with difficult choices to make. Fear is also voiced as the technology may lead to discrimination of people with possible diseases.
We invited Chieko Tamura, the only person in Japan who holds both American and Japanese certificates as a genetic counselor to share with us the current situation and challenges of genetic counseling and genetic testing.
(medium: Japanese)
■Theme
“Why
did Angelina Jolie undergo the surgery? – a perspective of a certified
genetic counselor from both Japan and the United States with regards to
the current situation and challenges of genetic counseling and genetic
testing.”
■Speaker
Chieko Tamura
Chieko Tamura originally studied pharmaceutical science, and has a Japanese national license as a pharmacist, since 1988. After working for a pharmaceutical company for thirteen years as a basic and clinical research scientist and a product manager, she went to the U.S.A. as a Fulbright scholar and studied genetic counseling at the joint graduate program of the National Human Genome Research Institute and Johns Hopkins University School of Public Health, and graduated in 2003 getting the master’s degree. She has been certified as a genetic counselor by the American Board of Genetic Counseling as well as the Japanese Board of Genetic Counseling. She is currently the only person who holds both American and Japanese certificates as a genetic counselor, and is now a board member of the Japanese Association of Certified Genetic Counselors. After returning to Japan in 2003, she worked as a genetic counselor, at many different medical institutions, including the Japan’s National Center for Child Health and Development, several university hospitals and major fertility clinics, covering a variety of conditions, including prenatal, pediatrics, adult genetics, cancer genetics, neurogenetics, and infertility, etc. Ms. Tamura also worked as an associate professor for five years at one of the newly established genetic counseling training graduate programs at Ochanomizu University in Tokyo. She has been working as an advisor to several patient and family support groups, with Marfan syndrome, Turner syndrome, prion diseases, familial colon cancer, spinocerebellar ataxia, etc.
■Date and Time
Sep 19, 2013 8:00am-9:00am
■Venue
GARB Marunouchi (2-2-3 Marunouchi, Chiyoda-ku, Tokyo)
Exhibition date:2013-09-19
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Policy Recommendations] Improving Patient Access to Genomic Cancer Medicine (August 10, 2023)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
Featured Posts
-
2026-06-04
[Registration Open] (Webinar) The 3rd J-PEP Seminar “Social Participation of People with Intractable Diseases and the Potential of a New Way of Working — ‘RD Workers’ — Lessons from Policy Advocacy Practice” (July 22, 2026)
-
2026-06-15
[Registration Open] (Hybrid Format) Multidisciplinary Symposium for Cardiology, Nephrology, and Metabolic Medicine “Future Actions for Making Full Use of the Health Checkup System: Connecting Checkups to Treatment From the Perspective of Data Linkage” (July 6, 2026)
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-06-24
[Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
-
2026-07-02
[Research Report] Medical Practitioner Interviews on the Current State and Issues for Interdepartmental Collaboration in Clinical Practice for Chronic Kidney Disease (June 30, 2026)





